Coca-Cola (NYSE:KO) may switch from high fructose corn syrup (HFCS) to cane sugar in U.S. beverages following discussions with President Donald Trump and pressure from Health Secretary Robert F. Kennedy Jr.'s “Make America Healthy Again” campaign. Advocates argue cane sugar is a healthier alternative to HFCS, though both are considered nutritionally limited.
Coca-Cola already sells cane sugar versions abroad and in select U.S. stores under “Mexican Coke.” The company said more product updates are coming. Rival PepsiCo (NASDAQ:PEP) also signaled openness to using cane sugar if consumer demand rises.
However, shifting to cane sugar would require major supply chain overhauls, new labeling, and significant cost increases. Industry analysts estimate the switch could cost Coca-Cola over $1 billion due to price gaps and limited domestic sugar production.
The U.S. uses about 400 million bushels of corn annually for HFCS, roughly 2.5% of total corn output. Replacing this with cane sugar would likely slash corn demand, cutting farm income by an estimated $5.1 billion and pushing corn prices down by up to 34 cents per bushel, according to the Corn Refiners Association.
Producers like Archer-Daniels-Midland and Ingredion (NYSE:INGR), key suppliers of HFCS, saw stock declines on the news. ADM ships 4–4.5 billion pounds of HFCS annually, accounting for 6–7% of projected 2026 earnings.
The U.S. currently produces only 3.6 million metric tons of cane sugar annually—insufficient to meet new demand—while Trump’s 50% import tariff on Brazilian sugar, the world’s largest source, could worsen supply issues.
Analysts warn reformulating Coke’s recipe would disrupt bottling operations and raise prices, a burden unlikely to be absorbed by manufacturers or welcomed by cost-conscious consumers.


CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
OpenAI Executive Shake-Up Ahead of Anticipated 2026 IPO
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
KPMG UK Cuts 440 Audit Jobs Amid Low Attrition and Cooling Professional Services Demand
Europe's Aviation Sector on Track to Meet 2025 Green Fuel Mandate
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown 



